Skip to content

Clinical trials

Phase 1/2 Pulmonary Disease, Chronic Obstructive trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 1/2 Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20074
20092
20101
20133
20143
20161
20171
20183
20191
20211
20221
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Withdrawn3
Recruiting3
Suspended2
Terminated2
Unknown status1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital2
Adverum Biotechnologies, Inc.1
Ageless Regenerative Institute1
Baylor College of Medicine1
Beth Israel Deaconess Medical Center1
Corewell Health East1
Endo USA Inc., a Keenova Therapeutics Company1
Grifols Therapeutics LLC1
Hal C Charles1
Healeon Medical Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive26
Emphysema5
Lung Diseases5
Lung Diseases, Obstructive3
Bronchitis, Chronic2
Heart Failure2
Pulmonary Emphysema2
alpha 1-Antitrypsin Deficiency2
Anxiety Disorders1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.